Sign In
Buy PRQR
$1.72
-0.0600 (-3.37%)
At Close: Jul 31, 2026
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline
06:05pm, Friday, 12'th Aug 2022 Benzinga
Raymond James upgraded ProQR Therapeutics N.V. (NASDAQ: PRQR) to Outperform based on a high conviction that "RNA editing" emerges as an impactful field of therapeutics in coming years.
Related:
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
02:14pm, Friday, 12'th Aug 2022 Benzinga
Upgrades
Mizuho upgraded the previous rating for Safehold Inc (NYSE:SAFE) from Neutral to Buy. For the second quarter, Safehold had an EPS of $0.37, compared to year-ago quarter EPS of $0.28. At the
ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates
02:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
ProQR (PRQR) delivered earnings and revenue surprises of 15.38% and 9.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates
12:02pm, Thursday, 04'th Aug 2022
ProQR (PRQR) delivered earnings and revenue surprises of 15.38% and 9.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
08:23am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Expert Ratings for ProQR Therapeutics
02:04pm, Friday, 06'th May 2022 Benzinga
Within the last quarter, ProQR Therapeutics (NASDAQ:PRQR) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
2
0
0
0
L
ProQR (PRQR) Reports Q1 Loss, Tops Revenue Estimates
12:15am, Friday, 06'th May 2022 Zacks Investment Research
ProQR (PRQR) delivered earnings and revenue surprises of 12% and 16.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ProQR (PRQR) Reports Q1 Loss, Tops Revenue Estimates
09:49pm, Thursday, 05'th May 2022
ProQR (PRQR) delivered earnings and revenue surprises of 12% and 16.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ProQR Announces First Quarter 2022 Operating and Financial Results
08:30pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t
Bears are Losing Control Over ProQR (PRQR), Here's Why It's a 'Buy' Now
01:55pm, Tuesday, 03'rd May 2022 Zacks Investment Research
After losing some value lately, a hammer chart pattern has been formed for ProQR (PRQR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions
ProQR (PRQR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
07:02pm, Thursday, 28'th Apr 2022 Zacks Investment Research
ProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ProQR (PRQR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04:33pm, Thursday, 28'th Apr 2022
ProQR (PRQR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022
08:10pm, Tuesday, 26'th Apr 2022 GlobeNewswire Inc.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of tra
ProQR to Participate in the Kempen Life Sciences Conference
08:30pm, Tuesday, 19'th Apr 2022 GlobeNewswire Inc.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of t
